- lymphoid neoplasms / IMPC
- hyperplasia / IMPC
- increased blood urea nitrogen level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased leukocyte cell number / IMPC
- decreased circulating LDL cholesterol level / IMPC
- increased circulating fructosamine level / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating creatinine level / IMPC
- decreased total body fat amount / IMPC
- increased bone mineral density / IMPC
- neoplasm / IMPC
C57BL/6N-Setd1atm1b(EUCOMM)Wtsi/WtsiCnbc
Status | Available to order |
EMMA ID | EM:14244 |
International strain name | C57BL/6N-Setd1atm1b(EUCOMM)Wtsi/WtsiCnbc |
Alternative name | EPD0027_4_H10 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Setd1atm1b(EUCOMM)Wtsi |
Gene/Transgene symbol | Setd1a |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0027_4_H10. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele using a cell permeable HTN-Cre as described in doi:10.1007/s11248-013-9764-x. Click here for more information on EUCOMM final vectors. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Animals used for archiving | heterozygous C57BL/6N |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- increased bone mineral density / MGI
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- decreased leukocyte cell number / MGI
- failure to gastrulate / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating alkaline phosphatase level / MGI
- decreased rib number / MGI
- decreased circulating cholesterol level / MGI
- cellular phenotype / MGI
- abnormal cell physiology / MGI
- abnormal DNA methylation / MGI
- decreased total body fat amount / MGI
- embryonic lethality between implantation and somite formation, complete penetrance / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).